ArticleBMC pregnancy and childbirth2026
Feasibility of direct surgical management for early-stage cervical pregnancy: a multicenter retrospective study.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCervical pregnancy (CP) is a rare ectopic pregnancy associated with life-threatening complications if managed improperly. There is currently no consensus on optimal management, and current evidence is largely limited to case reports. In this study, we retrospectively analyzed the clinical data of 178 patients with CP to evaluate the safety and efficacy of direct surgical treatment versus surgery after pretreatment with UAE or methotrexate (MTX).
methods178 CP patients from three tertiary hospitals were retrospectively categorized into surgery group (surgery alone), uterine artery embolism (UAE) group (surgery after UAE) and methotrexate (MTX) group (surgery after MTX) based on their treatments. The primary outcome was intraoperative blood loss. Secondary outcomes—including treatment success rate, operative duration, hospital stay length, hospitalization cost, blood transfusion rate, and β-hCG/menstrual recovery—were analyzed to assess the safety and efficacy of each management approach.
resultsNo significant differences in intraoperative blood loss, success rate, or operative time were found between groups. The surgery group, however, had a shorter hospital stay than the UAE and MTX groups, and lower costs than the UAE group. The average diameter of gestational sac (GS) or mass (OR 2.239, 95% CI 1.38–3.62) was identified as an independent risk factor for intraoperative hemorrhage.
conclusionDirect surgical management demonstrated favorable safety and efficacy in hemodynamically stable early-stage CP, providing benefits in reducing clinical burden, optimizing healthcare resource utilization, and preserving fertility. Moreover, the diameter of GS was an independent risk factor for hemorrhage, which should be comprehensively considered in choosing the optimal treatment for CP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.